GENEVA, July 6 -- CHINA MEDICAL UNIVERSITY filed a patent application (CN2025/144397) for “USE OF BIOMARKER IN METASTASIS RISK DIAGNOSIS AND TREATMENT OF TUMOR LYMPH NODE”. With publication no. WO/2026/138744, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G01N 33/569
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....